Migraine: open trials in Portugal

• NCT04965675

  A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine

  Trial Treatment · Phase 3 · H. Lundbeck A/S

  Unidade Local De Saude De Almada-Seixal E.P.E., Almada · Unidade Local de Saúde de Coimbra, E.P.E., Coimbra · Unidade Local de Saude de Sao Joao E.P.E., Porto

  Registry updated 2026-10-16

• NCT05164172

  A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine

  Trial Treatment · Phase 3 · H. Lundbeck A/S

  Unidade Local De Saude De Almada-Seixal E.P.E., Almada · CCAB Centro Clinico Academico Braga Associacao, Braga · Unidade Local de Saúde de Coimbra, E.P.E., Coimbra · Hospital Cuf Descobertas S.A., Lisbon · Unidade Local de Saude de Sao Joao E.P.E., Porto · Unidade Local De Saude De Santo Antonio E.P.E., Porto

  Registry updated 2026-10-14

• NCT05897320

  A Study of Eptinezumab in Pediatric Participants With Episodic Migraine

  Trial Treatment · Phase 3 · H. Lundbeck A/S

  Hospital de Braga, Braga · Hospital Pediátrico de Coimbra, Coimbra · Hospital Cuf Descobertas S.A., Lisbon · Centro Hospitalar Universitario de Santo Antonio - Centro Materno Infantil do Norte (CMIN), Porto · Centro Hospitalar Universitario de Sao Joao (CHUSJ), Porto

  Registry updated 2026-10-14

• NCT06810505

  A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

  Trial Treatment · Phase 3 · AbbVie

  Unidade Local De Saude De Almada-Seixal E.P.E., Almada · Unidade Local de Saúde de Coimbra, E.P.E., Coimbra · Hospital da Luz, S.A, Lisbon · Unidade Local De Saude De Santa Maria E.P.E., Lisbon · Unidade Local De Saude De Santo Antonio E.P.E., Porto

  Registry updated 2026-10-09

• NCT07159750

  Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine

  Research · Hospital Universitari Vall d'Hebron Research Institute

  Hospital Santa Maria Lisbon, Lisbon

  Registry updated 2025-09-08

• NCT05707949

  Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine

  Trial Treatment · Phase 3 · AbbVie

  Unidade Local De Saude De Almada-Seixal E.P.E., Almada · Unidade Local de Saúde de Coimbra, E.P.E., Coimbra · Hospital da Luz, S.A, Lisbon · Unidade Local De Saude De Santa Maria E.P.E., Lisbon · Unidade Local De Saude De Santo Antonio E.P.E., Porto

  Registry updated 2025-08-11

All Migraine trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error